328 related articles for article (PubMed ID: 28555779)
1. Pharmacology of oxidative stress: translational opportunities.
Daiber A; Di Lisa F; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1511-1513. PubMed ID: 28555779
[TBL] [Abstract][Full Text] [Related]
2. Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.
Zhang SY; Xu MJ; Wang X
Br J Pharmacol; 2018 Apr; 175(8):1230-1240. PubMed ID: 28407200
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function.
Daiber A; Di Lisa F; Oelze M; Kröller-Schön S; Steven S; Schulz E; Münzel T
Br J Pharmacol; 2017 Jun; 174(12):1670-1689. PubMed ID: 26660451
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches.
Cipak Gasparovic A; Zarkovic N; Zarkovic K; Semen K; Kaminskyy D; Yelisyeyeva O; Bottari SP
Br J Pharmacol; 2017 Jun; 174(12):1771-1783. PubMed ID: 27864827
[TBL] [Abstract][Full Text] [Related]
5. The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system.
Kietzmann T; Petry A; Shvetsova A; Gerhold JM; Görlach A
Br J Pharmacol; 2017 Jun; 174(12):1533-1554. PubMed ID: 28332701
[TBL] [Abstract][Full Text] [Related]
6. Antioxidants from black and green tea: from dietary modulation of oxidative stress to pharmacological mechanisms.
Peluso I; Serafini M
Br J Pharmacol; 2017 Jun; 174(11):1195-1208. PubMed ID: 27747873
[TBL] [Abstract][Full Text] [Related]
7. Targeting vascular (endothelial) dysfunction.
Daiber A; Steven S; Weber A; Shuvaev VV; Muzykantov VR; Laher I; Li H; Lamas S; Münzel T
Br J Pharmacol; 2017 Jun; 174(12):1591-1619. PubMed ID: 27187006
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on small molecules in cardiovascular diseases.
Wang X; Huang Y; Ji Y
Br J Pharmacol; 2018 Apr; 175(8):1111-1113. PubMed ID: 29574891
[TBL] [Abstract][Full Text] [Related]
9. The oxidative stress theory of disease: levels of evidence and epistemological aspects.
Ghezzi P; Jaquet V; Marcucci F; Schmidt HHHW
Br J Pharmacol; 2017 Jun; 174(12):1784-1796. PubMed ID: 27425643
[TBL] [Abstract][Full Text] [Related]
10. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
11. ROS in gastrointestinal inflammation: Rescue Or Sabotage?
Aviello G; Knaus UG
Br J Pharmacol; 2017 Jun; 174(12):1704-1718. PubMed ID: 26758851
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases.
Carrizzo A; Forte M; Damato A; Trimarco V; Salzano F; Bartolo M; Maciag A; Puca AA; Vecchione C
Food Chem Toxicol; 2013 Nov; 61():215-26. PubMed ID: 23872128
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress detection: what for? Part II.
Palmieri B; Sblendorio V
Eur Rev Med Pharmacol Sci; 2007; 11(1):27-54. PubMed ID: 17405347
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant effects of resveratrol in the cardiovascular system.
Xia N; Daiber A; Förstermann U; Li H
Br J Pharmacol; 2017 Jun; 174(12):1633-1646. PubMed ID: 27058985
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species: key regulators in vascular health and diseases.
Chen Q; Wang Q; Zhu J; Xiao Q; Zhang L
Br J Pharmacol; 2018 Apr; 175(8):1279-1292. PubMed ID: 28430357
[TBL] [Abstract][Full Text] [Related]
16. New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases.
Di Lisa F; Giorgio M; Ferdinandy P; Schulz R
Br J Pharmacol; 2017 Jun; 174(12):1690-1703. PubMed ID: 26990284
[TBL] [Abstract][Full Text] [Related]
17. Role of antioxidants in redox regulation of diabetic cardiovascular complications.
Turan B
Curr Pharm Biotechnol; 2010 Dec; 11(8):819-36. PubMed ID: 20874678
[TBL] [Abstract][Full Text] [Related]
18. The current state of GPCR-based drug discovery to treat metabolic disease.
Sloop KW; Emmerson PJ; Statnick MA; Willard FS
Br J Pharmacol; 2018 Nov; 175(21):4060-4071. PubMed ID: 29394497
[TBL] [Abstract][Full Text] [Related]
19. Highlighted mechanistic aspects in the chemical biology of reactive sulfur species.
Nagy P; Schwarz G; Kopriva S
Br J Pharmacol; 2019 Feb; 176(4):511-513. PubMed ID: 30680717
[TBL] [Abstract][Full Text] [Related]
20. Redox-based therapeutics in neurodegenerative disease.
McBean GJ; López MG; Wallner FK
Br J Pharmacol; 2017 Jun; 174(12):1750-1770. PubMed ID: 27477685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
